Grants and Contributions:
Title:
UK Multisector - BioM - MICRO-HTUO: Utilizing novel computational drug discovery technologies to develop a therapy for osteoporosis.
Agreement Number:
1035013
Agreement Value:
$499,000.00
Agreement Date:
Sep 1, 2025 - Mar 31, 2027
Description:
As part of the international consortium project "UK Multisector - BioM - MICRO-HTUO”, this project will focus on the validation of the AtomForge platform through the development of a novel treatment for Osteoporosis. The project will demonstrate the real world performance of the platform for use in drug discovery and optimization applications, while demonstrating a more rapid drug discovery method that couples the platform's experimental predictions with the UK partner's experimental methods.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6H 4B1
Reference Number:
172-2025-2026-Q2-1035013
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
709332134
Recipient Type:
For-profit organization
Recipient's Operating Name:
HTuO Biosciences
Recipient's Legal Name:
HTUO Biosciences Inc.
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410